Literature DB >> 8781772

Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes.

M Porta1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8781772     DOI： 10.1007/bf00418548

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  60 in total

Review 1.  Pharmacology of smooth muscle cell replication.

Authors:  C L Jackson; S M Schwartz
Journal:  Hypertension       Date:  1992-12       Impact factor: 10.190

2.  Circulating prostacyclin may be reduced in diabetes.

Authors:  C T Dollery; L A Friedman; C N Hensby; E Kohner; P J Lewis; M Porta; J Webster
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

3.  Elevated plasma endothelin in patients with diabetes mellitus.

Authors:  K Takahashi; M A Ghatei; H C Lam; D J O'Halloran; S R Bloom
Journal:  Diabetologia       Date:  1990-05       Impact factor: 10.122

Review 4.  Mechanisms of new vessel formation in the retina.

Authors:  J V Forrester
Journal:  Diabet Med       Date:  1987 Sep-Oct       Impact factor: 4.359

Review 5.  Pathophysiology of myocardial reperfusion.

Authors:  K A Fox; J E Saffitz; P B Corr
Journal:  Cardiol Clin       Date:  1987-02       Impact factor: 2.213

6.  Effect of high glucose on formation of extracellular matrix components by cultured rat heart endothelial cells.

Authors:  M J Spiro; Q He; M L D'Autilia
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

7.  Ticlopidine treatment reduces the progression of nonproliferative diabetic retinopathy. The TIMAD Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1990-11

8.  Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells.

Authors:  E Cagliero; T Roth; S Roy; M Lorenzi
Journal:  Diabetes       Date:  1991-01       Impact factor: 9.461

9.  Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.

Authors:  A Sivalingam; J Kenney; G C Brown; W E Benson; L Donoso
Journal:  Arch Ophthalmol       Date:  1990-06

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245
View more
  5 in total

1.  Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy.

Authors:  B O Boehm; G Lang; O Volpert; P M Jehle; A Kurkhaus; S Rosinger; G K Lang; N Bouck
Journal:  Diabetologia       Date:  2003-03-01       Impact factor: 10.122

2.  Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study.

Authors:  M T Schram; N Chaturvedi; C G Schalkwijk; J H Fuller; C D A Stehouwer
Journal:  Diabetologia       Date:  2005-02-04       Impact factor: 10.122

3.  Vascular complications and diabetes: current therapies and future challenges.

Authors:  Abbott L Willard; Ira M Herman
Journal:  J Ophthalmol       Date:  2012-01-09       Impact factor: 1.909

4.  Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy.

Authors:  Thanh T Nguyen; Ryo Kawasaki; Jie Jin Wang; Andreas J Kreis; Jonathan Shaw; Walthard Vilser; Tien Y Wong
Journal:  Diabetes Care       Date:  2009-07-29       Impact factor: 17.152

5.  Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes.

Authors:  Martina Tomić; Spomenka Ljubić; Snježana Kaštelan; Antonela Gverović Antunica; Anamarija Jazbec; Tamara Poljičanin
Journal:  Mediators Inflamm       Date:  2013-12-02       Impact factor: 4.711
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.